Funder: National Institutes of Health (NIH)
Due Dates: December 9, 2025 (forecasted)
Funding Amounts: Estimated total funding $6,000,000; ~15 awards anticipated; UG3/UH3 activity code
Summary: Supports development of innovative tools and technologies to identify, characterize, and target senescent cell types in vivo to advance understanding of cellular senescence in health and disease.
Key Information: This is a forecasted opportunity; applications are not yet being accepted.